论文部分内容阅读
目的:研究胃癌及癌前病变患者血清中CEA,CA19-9和CA125的水平及其临床意义。方法:用免疫荧光技术检测40例胃癌患者,35例胃癌术后患者,20例癌前病变患者和39例正常人血清中CEA,CA19-9和CA125的水平,结果:胃癌患者血清中CEA,CA19-9和CA125的水平分别为15.21±2.01,51.28±3.22和43.21±5.71,阳性率分别为52.5%,40%和65%,联合检测的阳性率为92.5%,结论:血清中CEA,CA19-9和CA125的检测对胃癌